CERT
Certara, Inc. · NASDAQ
- Sector Technology Services
- Industry Packaged Software
- Website certara.com
- Employees(FY) 1150
- ISIN US15687V1098
Performance
+2.82%
1W
-17.21%
1M
-21.4%
3M
-23.31%
6M
-21.26%
YTD
-22.1%
1Y
Profile
Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access. Further, company offers software, comprising mechanistic biosimulation platform, empirical PK/PD biosimulation platform, data standardization and compliance software, scientific informatics platform, clinical outcomes databases for biosimulation, authoring and management of regulatory submissions platform, and market access communication platform. The company serves biopharmaceutical companies, and academic and government institutions. It has operations in the United States, Australia, Canada, China, France, Germany, India, Italy, Japan, Luxembourg, the Netherlands, the Philippines, Poland, Portugal, Spain, Switzerland, and the United Kingdom. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.
Investment Analysis Report: CERT
Overview
In this investment analysis report, we will delve into the financial statements of CERT, a company operating in the Technology Services sector within the Packaged Software industry. We will analyze the company's financial health, earnings and revenue growth, profitability, operating margin, operating cas...
Technical Analysis of CERT 2024-05-31
Overview:
In analyzing the technical indicators for CERT over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and predictions for investors lookin...
Recent News & Updates
- 2023-03-01 18:43
Q4 2022 Certara Inc Earnings Call(Yahoo Finance)
- 2023-03-01 05:25
Certara, Inc. (CERT) Tops Q4 Earnings and Revenue Estimates(Yahoo Finance)
- 2023-03-01 03:16
- 2023-03-01 03:15
- 2023-02-27 03:30
- 2023-02-01 03:30
- 2023-01-08 22:40
CERT vs. PBYI: Which Stock Should Value Investors Buy Now?(Yahoo Finance)
- 2023-01-03 18:31
- 2022-12-23 05:35
- 2022-12-08 03:30
- 2022-11-26 08:01
- 2022-11-11 03:28
Why Certara's Shares Rose 37.7% This Week(Yahoo Finance)
- 2022-11-07 06:05
Certara, Inc. (CERT) Q3 Earnings Miss Estimates(Yahoo Finance)
- 2022-11-07 03:15
Certara Reports Third Quarter 2022 Financial Results(Yahoo Finance)
- 2022-11-06 19:00
- 2022-11-02 05:00
Certara to Participate in Upcoming Investor Conferences(Yahoo Finance)
- 2022-10-18 20:00
- 2022-10-12 19:45
- 2022-08-30 20:00
Certara to Participate in Upcoming Investor Conferences(Yahoo Finance)
- 2022-08-11 04:38
Certara Announces Secondary Offering(Yahoo Finance)
- 2022-08-09 09:00
- 2022-08-09 07:45
Certara, Inc. (CERT) Q2 Earnings and Revenues Miss Estimates(Yahoo Finance)
- 2022-08-09 05:00
- 2022-08-09 04:15
Certara Reports Second Quarter 2022 Financial Results(Yahoo Finance)
- 2022-08-04 20:00
- 2022-08-01 03:02
- 2022-07-27 20:00
- 2022-07-24 20:00
- 2022-07-12 20:00
Certara Appoints Eran Broshy as New Independent Board Member(Yahoo Finance)
- 2022-07-11 20:00